A Study of AMG 193 in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

649

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

December 30, 2026

Study Completion Date

November 27, 2028

Conditions
Advanced MTAP-null Solid Tumors
Interventions
DRUG

AMG 193

AMG 193: Orally via tablet

DRUG

Docetaxel

Docetaxel: Intravenous infusion

DRUG

Comparator AMG 193 Test Tablet

Comparator AMG 193 test tablet: Orally via tablet. Only participants in the DSPS group of the Part 1a, Phase 1: AMG 193 Monotherapy Dose Exploration, and Part 1j, Phase 1 arms will receive comparator AMG 193 test tablet.

Trial Locations (75)

1200

RECRUITING

Universite Catholique de Louvain Cliniques Universitaires Saint Luc, Brussels

1211

RECRUITING

Hopitaux Universitaires de Geneve, Geneva

2050

RECRUITING

Chris OBrien Lifehouse, Camperdown

2650

RECRUITING

Universitair Ziekenhuis Antwerpen, Edegem

3000

RECRUITING

Universitair Ziekenhuis Leuven - Campus Gasthuisberg, Leuven

3002

RECRUITING

Epworth Healthcare, East Melbourne

3010

RECRUITING

Inselspital Bern, Bern

3050

RECRUITING

Peter MacCallum Cancer Centre, Parkville

3500

RECRUITING

Jessa Ziekenhuis - Campus Virga Jesse, Hasselt

5020

RECRUITING

Landeskrankenhaus Salzburg, Salzburg

6500

RECRUITING

Istituto Oncologico della Svizzera Italiana, Bellinzona

8036

RECRUITING

Medizinische Universitaet Graz, Graz

8091

RECRUITING

Universitaetsspital Zuerich, Zurich

9000

RECRUITING

Universitair Ziekenhuis Gent, Ghent

9007

RECRUITING

Kantonsspital Sankt Gallen, Sankt Gallen

10002

RECRUITING

National Taiwan University Hospital, Taipei

10016

RECRUITING

New York University Grossman School of Medicine and New York University Langone Hospitals, New York

11042

RECRUITING

Northwell Health Monter Cancer Center, Lake Success

11217

RECRUITING

Taipei Veterans General Hospital, Taipei

13620

RECRUITING

Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do

15232

RECRUITING

University of Pittsburgh Medical Center, Pittsburgh

19106

RECRUITING

University of Pennsylvania, Philadelphia

19107

RECRUITING

Thomas Jefferson University, Philadelphia

20817

RECRUITING

American Oncology Partners, PA, Bethesda

21000

RECRUITING

Centre Georges Francois Leclerc, Dijon

21201

RECRUITING

University of Maryland Medical Center, Baltimore

22031

RECRUITING

Virginia Cancer Specialists PC, Fairfax

22908

RECRUITING

University of Virginia Cancer Center, Charlottesville

27710

RECRUITING

Duke University, Durham

32224

RECRUITING

Roswell Park Cancer Institute, Buffalo

33063

TERMINATED

D and H Cancer Research Center, Margate

33305

TERMINATED

Linkou Chang Gung Memorial Hospital of Chang Gung Medical Foundation, Taoyuan District

33321

TERMINATED

Boca Raton Clinical Research Medical Center Inc, Tamarac

44106

RECRUITING

University Hospitals Cleveland Medical Center, Cleveland

46202

TERMINATED

Indiana University, Indianapolis

46250

RECRUITING

Community Health Network MD Anderson Cancer Center - North, Indianapolis

46526

COMPLETED

Goshen Health Systems, Goshen

48202

RECRUITING

Henry Ford Cancer Detroit (Brigitte Harris Cancer Pavilion), Detroit

54104

RECRUITING

Sanford Oncology Clinic and Pharmacy, Sioux Falls

59000

RECRUITING

Centre Oscar Lambret, Lille

63110

RECRUITING

Washington University, St Louis

69120

RECRUITING

Universitaetsklinikum Heidelberg, Heidelberg

70403

RECRUITING

National Cheng Kung University Hospital, Tainan City

75013

RECRUITING

Hopitaux Universitaires Pitie Salpetriere - Charles Foix, Paris

75230

RECRUITING

Mary Crowley Cancer Research, Dallas

77030

TERMINATED

Center for Oncology and Blood Disorders, Houston

RECRUITING

University of Texas MD Anderson Cancer Center, Houston

77339

RECRUITING

Lumi Research, Kingwood

78229

RECRUITING

South Texas Accelerated Research Therapeutics, San Antonio

89081

RECRUITING

Universitaetsklinikum Ulm, Ulm

91010

RECRUITING

City of Hope National Medical Center, Duarte

91204

TERMINATED

California Research Institute, Glendale

93030

TERMINATED

Fomat Medical Research, Oxnard

94158

RECRUITING

University of California at SF, San Francisco

94800

RECRUITING

Gustave Roussy, Villejuif

97078

RECRUITING

Universitaetsklinikum Wuerzburg, Würzburg

200123

RECRUITING

Shanghai East Hospital, Shanghai

200433

RECRUITING

Shanghai Pulmonary Hospital, Shanghai

350014

RECRUITING

Fujian Cancer Hospital, Fuzhou

350028

RECRUITING

Mengchao Hepatobiliary hospital of Fujian Medical University, Fuzhou

400044

RECRUITING

Chongqing University Cancer Hospital, Chongqing

08903

RECRUITING

Rutgers Cancer Institute of New Jersey, New Brunswick

T6G 1Z2

RECRUITING

Cross Cancer Institute, Edmonton

M5G 2M9

RECRUITING

Princess Margaret Cancer Centre, Toronto

06120

RECRUITING

Universitaetsklinikum Halle - Saale, Halle

Unknown

RECRUITING

Queen Mary Hospital, The University of Hong Kong, Hong Kong

RECRUITING

Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, New Territories

464-8681

RECRUITING

Aichi Cancer Center, Nagoya

277-8577

RECRUITING

National Cancer Center Hospital East, Kashiwa-shi

104-0045

RECRUITING

National Cancer Center Hospital, Chuo-ku

03080

RECRUITING

Seoul National University Hospital, Seoul

03722

RECRUITING

Severance Hospital Yonsei University Health System, Seoul

05505

RECRUITING

Asan Medical Center, Seoul

W1G 6AD

RECRUITING

Sarah Cannon Research Institute UK, London

SM2 5PT

RECRUITING

Royal Marsden Hospital, Sutton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY